Fig. 3
From: CISD3 is a prognostic biomarker and therapeutic target in pan-cancer

Correlation analysis of CISD3 expression with prognosis and diagnosis in pan-cancer. (A) Overall survival (OS) of CISD3 assessed based on the GEPIA database. (B) OS of CISD3 assessed based on the Kaplan–Meier plotter database. (C) Diagnostic ROC curve of CISD3 in cancer. Univariate COX analysis of CISD3 in NSCLC (D), CRC (E), and KIRC (F). (G) Multivariate COX analysis of CISD3 in KIRC. (H) Nomogram predicting 1-year, 3-year, and 5-year OS in KIRC.